Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders | ||
| By: PR Newswire Association LLC. - 18 Apr 2014 | Back to overview list |
|
WEST HARTFORD, Conn., April 18, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders" at GIIResearch.com Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; among the other types of PVD are chronic venous insufficiency, deep vein thrombosis, and pulmonary embolism. In 2012, approximately 3.8 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an estimated $1.67 billion in corresponding product sales. The number of diagnostic and therapeutic interventions for PVD management is expected to increase at a compound annual rate of 2.0% during the forecast period covered by this report, reaching nearly 4.2 million in the year 2013. Sales of products to perform these interventional procedures are projected to increase at a compound annual rate of 6.0% during the forecast period covered by this report, reaching an estimated $2.2 billion in the year 2013. Covered topics in this report include angiography devices; catheter-directed thrombolysis products; drug-eluting balloon systems; cryotherapy products; endovascular embolization products; intravascular ultrasound systems; mechanical atherectomy systems; thrombectomy products; noninvasive peripheral vascular disease treatments; peripheral transluminal angioplasty devices; surgical/endoscopic peripheral vascular disease treatments; vascular puncture closure devices; and vena cava filters, among others. Table of Contents Executive Summary
More detailed information is available at Media Contact: Joe Malley, Global Information, Inc., 860-674-8796, US-marketing@gii.co.jp News distributed by PR Newswire iReach: https://ireach.prnewswire.com SOURCE Global Information Inc. |
||
|
|
||
| Copyright 2014 PR Newswire Association LLC. | Back to overview list | |